{"id":"W1983086187","doi":"10.1007/s10637-005-2905-1","title":"Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Bayer (Canada); Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Camptothecin; Lethargy; Vomiting; Toxicity; Nausea; Pharmacokinetics; Diarrhea; Pharmacology; Gastroenterology; Anesthesia; Internal medicine; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009618339,0.0001923663,0.0002082844,0.00007333815,0.0000548337,0.00001773675,0.0001176939,0.00006825032,0.00002516818],"category_scores_gemma":[0.0000279821,0.0001769254,0.00003429013,0.00009053191,0.0000773733,0.0000168387,0.00006417106,0.00005315219,0.00000117463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002632105,"about_ca_system_score_gemma":0.0002720676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003675266,"about_ca_topic_score_gemma":0.000106634,"domain_scores_codex":[0.998886,0.00003279899,0.0003189098,0.0003571474,0.0002095121,0.0001956144],"domain_scores_gemma":[0.9993357,0.00002700417,0.0001790459,0.0001765392,0.0001475195,0.0001342001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004681339,0.002143258,0.003761237,0.00007205502,0.0002120829,0.000002938378,0.005121009,0.00121625,0.958216,0.0002231324,0.0007941361,0.02355658],"study_design_scores_gemma":[0.0895059,0.01920821,0.01394892,0.0003216029,0.0001933992,0.00001015871,0.001638803,0.00117969,0.8376291,0.002184597,0.0331486,0.001030983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998201,0.0001771193,0.0001565041,0.0001900919,0.00005853884,0.001015211,0.000128144,0.000006527963,0.00006689889],"genre_scores_gemma":[0.9965184,0.00003475407,0.001651364,0.0007679438,0.0001037786,0.0001301354,0.0002137335,0.00002656031,0.0005532925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1205868,"threshold_uncertainty_score":0.721481,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01063012803762387,"score_gpt":0.2795822471758359,"score_spread":0.268952119138212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}